News About: Pharm. Industry
Han named legal counsel of Gilead Sciences KoreaHan Man-hee, former director of Janssen Korea and Dong-A Pharmaceutical, was named as a legal counsel as of Jan. 21, Gilead Sciences Korea said.
She will be responsible for o...
|
Drugmakers calls for increasing R&D budget to 1 trillion won
Representatives from the Korea Pharmaceutical Manufacturers Association, the Korea Drug Research Association and the Korea Research-based Pharmaceutical Industry Association are calling for the government to support t...
12 Korean drugmakers at risk of losing “innovative drug firm’ status
The government selected 43 companies last June as “innovative pharmaceutical firms.” Those in the category receive various benefits, including priority to participate in state-run research and development projects, ta...
Dong-A’s spin-off plan stirs controversy
Dong-A Pharma is grappling with controversy over corporate governance as it plans to set up a holding company and put its cash cow energy drink business, Bacchus, under an unlisted firm.
The case is drawing more at...
MSD Korea begins recall of HDL cholesterol drugMSD Korea, the Korean unit of Merck & Co, said Wedneday it is recalling Tredaptive, its medicine to raise "good" HDL cholesterol levels.
The recalled five products are S3727 ...
|
Pfizer Korea to cut labor for restructuring
Pfizer Korea is undertaking large-scale restructuring in an effort to cope with the government’s decision to slash drug prices.
The company said that it will soon accept applications from 80 employees including mid...
Drug rebate scandals baffle pharmaceutical industry
It is baffling to see large pharmaceutical firms being caught in a series of rebate scandals, industrial officials said.
Earlier this month, the prosecution indicted seven former and incumbent executives of the cou...
Local drugmakers lag behind in R&D spending
Korean drug companies are still lagging far behind their overseas counterparts in research and development (R&D) investment, spawning fears that they will lose out.
Aggressive R&D investment has been the main drive...
JW Holdings wins $10 million drug contract
JW Holdings has won a contract to supply $10 million worth of Q-roxin (balofloxacin), a quinolone antibiotic and hair dye Changpo(n) to the Chinese market, the Korean pharmaceutical firm said Monday.
The company sa...
LG Life Sciences to open large-scale research center in Seoul
LG Life Sciences said Monday it will invest 500 billion won in research and development (R&D) over the next five years, with a pharmaceutical and biomedicine research center to be built in Seoul.
In its business i...
